Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 26
2
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Go West, young man: in search of the A00 haplogroup among peoples of Western Cameroon

Welcome to our citizen-science research project on haplogroup A00 in Cameroon! Having successfully sampled...

Understanding how octopuses use scent to find food

Surprisingly, it has yet to be shown if octopuses can use odors to find food, it is often assumed that they...

Using a hyperbaric chamber and a specially designed ROV to collect deep water fish

The goal of this project is to use an ROV to catch Mesophotic Reef fish and a hyperbaric chamber to successfully...

Backer Badge Funded